This board aims to consult and support 20,000 patients in its first year and with its digital-first approach, utilise tech advancement in the field of healthcare to discuss over 30 patient cases in a day.
Just 0.29 percent of eligible patients from low socioeconomic background have received the treatment, finds a study by doctors from Tata Memorial Centre in Mumbai. Multiple insurances available in India do not support treatment with immunotherapy.
Oncologists at Tata Memorial Centre have tested a low-dose immunotherapy regimen that brings down treatment costs for head and neck cancers to Rs 3.3 lakh a year from Rs 62 lakh. In immunotherapy, cells derived from the patient’s own body are genetically re-engineered to fight against cancer cells.
Many Indian digital healthcare startups are focussed on accessibility and affordability, said David Shulkin, former US secretary of veterans affairs, who currently advises Indegene on using digital tools to help life sciences companies.
The Maharashtra government's move to cap CT scan test rates comes at a time when doctors have been relying heavily on CT scans to diagnose COVID-19 patients and assess the damage done to their lungs.
Same-day discharge is still a novel concept in Indian health care, but this company's growth is evidence that it is catching on
CNBC-TV18's Archana Shukla reports that India's grant of a compulsory licence to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe